ArticleThe Journal of reproduction and development2026
GM-CSF increases glucose uptake and mitochondrial activity and reduces reactive oxygen species levels in mouse cumulus-oocyte complexes during oocyte in vitro maturation.
Article in The Journal of reproduction and development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We have previously reported that the addition of granulocyte macrophage-colony stimulating factor (GM-CSF) during oocyte in vitro maturation (IVM) can increase embryo development in mice. The present study examined glucose uptake, mitochondrial activity, reactive oxygen species (ROS) levels, and the expression of key genes associated with these pathways in cumulus-oocyte complexes (COCs). The addition of 10 ng/ml GM-CSF during IVM increased glucose uptake at 15 min (3.45 vs. 3.48, P < 0.001) compared control. However, at 30 min (3.45 vs. 3.44, P < 0.05) and 60 min (3.45 vs. 3.46, P < 0.01), glucose levels were higher in the control. GM-CSF also increased mitochondrial membrane potential (MMP) in the outer area of COCs compared with the control at the end of IVM (1.92 vs. 2.42, P < 0.01), while no differences were observed in the intermediate and perinuclear areas. GM-CSF reduced MMP across all three regions in denuded oocytes compared with control (outer area 3.64 vs. 3.32, P < 0.05; intermediate 2.05 vs. 1.63, P < 0.01; perinuclear 1.59 vs. 1.28, P < 0.01). GM-CSF reduced ROS levels compared with the control at the end of IVM (6367.7 vs. 3935.8, P < 0.01). ROS levels were also reduced in denuded oocytes in the GM-CSF group with the control group (14870.0 vs. 7117.9, P < 0.001). GM-CSF increased the expression of key genes associated with mitochondrial function and ROS production in COCs at the end of IVM. Together, our findings suggest that GM-CSF increases glucose uptake in the cumulus cells which increases the supply of energy substrates to the oocyte increasing mitochondrial activity while reducing ROS levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.